Andrew J. Emerson

Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer), Idexx Laboratories

In the seat. First published here October 28, 2026; built from records as of October 28, 2026.

Andrew J. Emerson signed the annual report of Idexx Laboratories as Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer); the report was filed on February 20, 2026, the most recent filing in the record that ties Andrew J. Emerson to the seat.¹

Seats

The seat in the record

Company	Title as filed	Standing	Filings
Idexx Laboratories (IDXX) In Vitro & In Vivo Diagnostic Substances	Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)	In the seat	1

Company names link to the company's page in the record at CFO Tribune, which holds the seat history.

The record

Filing by filing, latest first

February 20, 202610-K filed
Andrew J. Emerson signed the annual report of Idexx Laboratories on Form 10-K as Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer), filed February 20, 2026.
/s/ Andrew J. Emerson Executive Vice President, Chief Financial Officer and Treasurer (Principal Financial and Accounting Officer)
[1] Annual report on Form 10-K by Idexx Laboratories, filed with the SEC on February 20, 2026. Read the filing. The record at CFO Tribune.

Sources

Annual report on Form 10-K, Idexx Laboratories. U.S. Securities and Exchange Commission, EDGAR, filed February 20, 2026. sec.gov; record.

Corrections and removal

If a line here is wrong, or Andrew J. Emerson wants this profile taken down, write to corrections@cfospotlights.com. Corrections are made on the page with a dated note; removal requests are answered within 72 hours. The underlying filings stay public at the SEC.